Signaling through OX40 (CD134) breaks peripheral T-cell tolerance

Nature Medicine

Volumn 7, Issue 8, 2001, Pages 907-912

  Bansal Pakala, P ^a   Gebre Hiwot Jember, A ^a   Croft, M ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIGENS, CD27; MICE; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0034881390     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/90942     Document Type: Article

References (44)

1. The mechanism of immunological paralysis
2. A theory of self-nonself discrimination
3. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo
4. Acquisition of immunologic self-tolerance
5. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation
6. T cell clonal anergy
7. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
8. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance
9. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
10. + T cells
11. + T-cell tolerance to T-cell priming through in vivo ligation of CD40
12. OX40 Ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses
13. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells
14. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion
15. Cloning of mouse OX40: A T-cell activation marker that may mediate T-B cell interactions
16. + T cells with homology to tumor necrosis factor
17. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection
18. OX40-ligand has a critical costimulatory role in dendritic cell: T cell interactions
19. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand
20. Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion
21. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells
22. Defective TCR expression in transgenic mice constructed using cDNA- based α- and β-chain genes under the control of heterologous regulatory elements
23. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
24. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand
25. A cell culture model for T lymphocyte clonal anergy
26. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody
27. Immunological activity of covalently linked T-cell epitopes
28. + cell subsets
29. T cell priming versus T cell tolerance induced by synthetic peptides
30. + T cells persist in vivo following induction of peripheral tolerance
31. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells
32. Engagement of the OX-40 receptor in vivo enhances antitumor immunity
33. Role of antigen-presenting cells in mediating tolerance and autoimmunity
34. + T cell- and IL-2-dependent mechanism
35. CTLA-4 blockade synergizes with tumor-derived granulocyte, macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
36. Enhancement of antitumor immunity by CTLA-4 blockade
37. Models of T cell anergy: Is there a common molecular mechanism?
38. + T cells
39. + T cells
40. Transactivation by AP-1 is a molecular target of T cell clonal anergy
41. + T cells express perturbed AP-1 and NF-κB transcription factors
42. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes
43. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB
44. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAFS-mediated NF-κB activation